News

Elizabeth Bulaeva (Eaves Lab) successfully defended her PhD thesis entitled “Analysis of a de novo c-MYC-induced model of human Acute Myeloid Leukemia”.

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia. 

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. 

Congratulations to Afsaneh who has been awarded a 4YF from the IOP program for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.

Congratulations to Liam who has been awarded a B.C. Graduate Scholarship for his project entitled “Investigating the anti-leukemic effects of tumor-suppressor microRNAs in acute myeloid leukemia”.​

Congratulations to Sibyl Drissler (Hoodless Lab) who has been awarded a CIHR Canada Graduate Scholarship Master's (CGSM) Award.

Congratulations to Louis-Alexandre Fournier (Stirling Lab) who has been awarded a CIHR Doctoral Award (Frederick Banting and Charles Best Canada Graduate Scholarship) for his project entitled “Investigating the role of ARID1A loss in cancer and its effects on R-loop accumulation and genome instability”.